Brief: Theravance Biopharma Q1 Operating Income USD -14.434 Million
08/05/2025 21:05
May 08 (Reuters) - Theravance Biopharma Q1 adjusted net income USD -8.618 million. Q1 net income USD -13.579 million
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy